Literature DB >> 12604538

Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin.

Susan Boyle-Vavra1, Shaohui Yin, Mamatha Challapalli, Robert S Daum.   

Abstract

We found an increased abundance of pbpB-specific transcripts in vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolates compared with that found in paired, genetically identical, susceptible isolates. This difference in expression cannot be explained by differences in the pbpB promoter sequence. Since the factors controlling pbpB gene expression have remained largely unexplored, various conditions that might affect pbpB transcript abundance were examined. In both vancomycin-susceptible and VISA strains, pbpB expression varied with the growth phase, with the highest abundance of pbpB-specific transcripts detected during mid-log phase. Interestingly, both vancomycin and oxacillin were able to induce pbpB transcription above a constitutive level. When vancomycin was absent, one of the three pbpB-specific transcripts that were usually faintly detected in non-VISA strains was more readily detected in VISA strains during mid-log but not stationary phase. This transcript was enhanced in non-VISA strains by vancomycin induction. Gel shift assays indicated that an increased amount of the putative transcription factor that binds to both P1 and P1' promoter regions is present in the cytosol of vancomycin-induced cells. Neither the SigB sigma factor nor the quorum-sensing agr locus was required for growth phase-variable pbpB expression or transcriptional induction of pbpB by vancomycin or oxacillin. Also, MecI, MecR1, BlaI, and BlaR1, regulatory proteins that mediate beta-lactam-inducible expression of mecA and beta-lactamase, were not required for antibiotic induction of pbpB transcription. These data support the idea that pbpB expression is modulated by a trans-acting factor in response to the presence of the cell wall-active antibiotics vancomycin and oxacillin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604538      PMCID: PMC149319          DOI: 10.1128/AAC.47.3.1028-1036.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  Penicillin-binding protein-related factor A is required for proper chromosome segregation in Bacillus subtilis.

Authors:  L B Pedersen; P Setlow
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

Review 2.  Genetic basis of methicillin resistance in Staphylococcus aureus.

Authors:  B Berger-Bächi
Journal:  Cell Mol Life Sci       Date:  1999-11-30       Impact factor: 9.261

3.  Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method.

Authors:  M Kuroda; K Kuwahara-Arai; K Hiramatsu
Journal:  Biochem Biophys Res Commun       Date:  2000-03-16       Impact factor: 3.575

4.  Role of upstream sequences in the expression of the staphylococcal enterotoxin B gene.

Authors:  R Mahmood; S A Khan
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

5.  Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance.

Authors:  M Bischoff; M Roos; J Putnik; A Wada; P Glanzmann; P Giachino; P Vaudaux; B Berger-Bächi
Journal:  FEMS Microbiol Lett       Date:  2001-01-01       Impact factor: 2.742

6.  Inactivation of the methicillin resistance gene mecA in vancomycin-resistant Staphylococcus aureus.

Authors:  K Sieradzki; S W Wu; A Tomasz
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

7.  Sigma(B) activity depends on RsbU in Staphylococcus aureus.

Authors:  P Giachino; S Engelmann; M Bischoff
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

8.  Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

Authors:  L Cui; H Murakami; K Kuwahara-Arai; H Hanaki; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

9.  A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus.

Authors:  Y Katayama; T Ito; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

10.  A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates.

Authors:  S Boyle-Vavra; H Labischinski; C C Ebert; K Ehlert; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

View more
  24 in total

1.  Cefoxitin does not induce production of penicillin binding protein 2a in methicillin-susceptible Staphylococcus aureus strains.

Authors:  Ana Lúcia da Costa Darini; Izabel Cristina Vanzato Palazzo
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  pbp2229-mediated nisin resistance mechanism in Listeria monocytogenes confers cross-protection to class IIa bacteriocins and affects virulence gene expression.

Authors:  Anne Gravesen; Birgitte Kallipolitis; Kim Holmstrøm; Poul Erik Høiby; Manilduth Ramnath; Susanne Knøchel
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

3.  Roles of DNA sequence and sigma A factor in transcription of the vraSR operon.

Authors:  Antoaneta Belcheva; Vidhu Verma; Artyom Korenevsky; Michael Fridman; Krishan Kumar; Dasantila Golemi-Kotra
Journal:  J Bacteriol       Date:  2011-10-21       Impact factor: 3.490

4.  VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus.

Authors:  Shaohui Yin; Robert S Daum; Susan Boyle-Vavra
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.

Authors:  Regina Fernandez; Liliana I Paz; Roberto R Rosato; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

6.  In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.

Authors:  N McCallum; H Karauzum; R Getzmann; M Bischoff; P Majcherczyk; B Berger-Bächi; R Landmann
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

7.  Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels.

Authors:  Kelly M Hines; Tianwei Shen; Nathaniel K Ashford; Adam Waalkes; Kelsi Penewit; Elizabeth A Holmes; Kathryn McLean; Stephen J Salipante; Brian J Werth; Libin Xu
Journal:  J Antimicrob Chemother       Date:  2020-05-01       Impact factor: 5.790

8.  Evaluation of ceftaroline activity against heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate methicillin-resistant S. aureus strains in an in vitro pharmacokinetic/pharmacodynamic model: exploring the "seesaw effect".

Authors:  Brian J Werth; Molly E Steed; Glenn W Kaatz; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

9.  Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain.

Authors:  Fred Goldstein; Jiri Perutka; Arabela Cuirolo; Konrad Plata; Diego Faccone; Joanne Morris; Aude Sournia; Marie Dominique Kitzis; Aicha Ly; Gordon Archer; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

10.  Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or -resistant Staphylococcus aureus.

Authors:  Roger Pechous; Nagender Ledala; Brian J Wilkinson; Radheshyam K Jayaswal
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.